RM Partners Research and Innovation fund for 2026/2027
RM Partners are pleased to announce the launch of the 4th round of the RM Partners Research and Innovation Fund for 2026/2027 and invite expressions of interest to be submitted for an opportunity to be awarded up to £200,000 to deliver a project across north west and south west London.
The aim of the RM Partners research and innovation fund is to provide cancer researchers, clinicians and non-clinicians in north west and south west London the opportunity to deliver significant projects that support the goals of RM Partner's Five Year Strategy and the recently published National Cancer Plan for England. Cancer Alliance research and innovation includes real-world implementation of innovations, where the scale of the Alliance population and clinical engagement and partnership drives rapid generation of evidence and adoption to serve our patient population.
Areas of priority this year include:
- cancer prevention
- equity in access and outcomes
- earlier diagnosis or improved survival in cancers where there has been little or no improvement in survival, such as pancreas, liver, oesophagus, ovarian cancers
- sustainable delivery models of personalised care in neighbourhood health settings
- technology to improve timely access to cancer-directed treatment.
Application guidance (PDF) is available.
Additional FAQs and timelines can be found on the
RM Partners website (click on the 2026/27 programme to expand)
A short Q&A session may be held online if there are enough requests, please send to
RM Partners to register your interest.
The deadline for submission using the
EOI template (Word document) is COP Friday 24 April 2026. Please share this with amongst your network and colleagues.